Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux

the U-BIOPRED Study Group

doi:10.1183/13993003.00453-2019

Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux

the U-BIOPRED Study Group

Group Tissing

Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review

18 Citaten (Scopus)

Originele taal-2	Engels
Artikelnummer	1900453
Tijdschrift	European Respiratory Journal
Volume	53
Nummer van het tijdschrift	6
DOI's	https://doi.org/10.1183/13993003.00453-2019
Status	Gepubliceerd - 1 jun. 2019

Toegang tot document

10.1183/13993003.00453-2019

Citeer dit

@article{065a23e3006047b8854fed5ec5dc65aa,

title = "Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux",

author = "{the U-BIOPRED Study Group} and Perotin, {Jeanne Marie} and Schofield, {James P.R.} and Wilson, {Susan J.} and Jonathan Ward and Joost Brandsma and Fabio Strazzeri and Aruna Bansal and Xian Yang and Anthony Rowe and Julie Corfield and Rene Lutter and Shaw, {Dominick E.} and Bakke, {Per S.} and Massimo Caruso and Barbro Dahl{\'e}n and Fowler, {Stephen J.} and Ildik{\'o} Horv{\'a}th and Peter Howarth and Norbert Krug and Paolo Montuschi and Marek Sanak and Thomas Sandstr{\"o}m and Kai Sun and Ioannis Pandis and Charles Auffray and {de Meulder}, Bertrand and Sousa, {Diane Lefaudeux Ana R.} and Dahlen, {Sven Erik} and Adcock, {Ian M.} and Chung, {Kian Fan} and Sterk, {Peter J.} and Skipp, {Paul J.} and Riley, {John H.} and Collins, {Jane E.} and Davies, {Donna E.} and Ratko Djukanovic and H. Ahmed and Banssal, {A. T.} and F. Baribaud and S. Bates and Bel, {E. H.} and J. Bigler and H. Bisgaard and Boedigheimer, {M. J.} and K. B{\o}nnelykke and P. Brinkman and E. Bucchioni and D. Burg and A. Bush and Louis Bont",

note = "Funding Information: Support statement: U-BIOPRED is supported through an Innovative Medicines Initiative Joint Undertaking under grant agreement number 115010, resources of which are composed of financial contribution from the European Union{\textquoteright}s Seventh Framework Program (FP7/2007–2013) and European Federation of Pharmaceutical Industries and Associations companies{\textquoteright} in-kind contribution (www.imi.europa.eu). J.M. Perotin was supported by the European Respiratory Society (fellowship LTRF 2017), Association R{\'e}gionale pour l{\textquoteright}Aide aux Insuffisants Respiratoires de Champagne-Ardenne, Association Nationale de Formation Continue en Allergologie, Association des Allergologues de Champagne-Ardenne and Association des Pneumologues de Champagne-Ardenne. Funding information for this article has been deposited with the Crossref Funder Registry. Funding Information: Acknowledgements: J-M. Perotin is the recipient of a European Respiratory Society Long-Term Fellowship (LTRF 2017) and received additional funding to support her research in Southampton, UK, from the Association R{\'e}gionale pour l{\textquoteright}Aide aux Insuffisants Respiratoires de Champagne-Ardenne, Association Nationale de Formation Continue en Allergologie, Association des Allergologues de Champagne-Ardenne and Association des Pneumologues de Champagne-Ardenne. This funding is gratefully acknowledged. Funding Information: U-BIOPRED is supported through an Innovative Medicines Initiative Joint Undertaking under grant agreement number 115010, resources of which are composed of financial contribution from the European Union's Seventh Framework Program (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations companies' in-kind contribution (www.imi.europa.eu). J.M. Perotin was supported by the European Respiratory Society (fellowship LTRF 2017), Association R?gionale pour l'Aide aux Insuffisants Respiratoires de Champagne-Ardenne, Association Nationale de Formation Continue en Allergologie, Association des Allergologues de Champagne-Ardenne and Association des Pneumologues de Champagne-Ardenne. Funding information for this article has been deposited with the Crossref Funder Registry.",

year = "2019",

month = jun,

day = "1",

doi = "10.1183/13993003.00453-2019",

language = "English",

volume = "53",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "6",

}

TY - JOUR

T1 - Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux

AU - the U-BIOPRED Study Group

AU - Perotin, Jeanne Marie

AU - Schofield, James P.R.

AU - Wilson, Susan J.

AU - Ward, Jonathan

AU - Brandsma, Joost

AU - Strazzeri, Fabio

AU - Bansal, Aruna

AU - Yang, Xian

AU - Rowe, Anthony

AU - Corfield, Julie

AU - Lutter, Rene

AU - Shaw, Dominick E.

AU - Bakke, Per S.

AU - Caruso, Massimo

AU - Dahlén, Barbro

AU - Fowler, Stephen J.

AU - Horváth, Ildikó

AU - Howarth, Peter

AU - Krug, Norbert

AU - Montuschi, Paolo

AU - Sanak, Marek

AU - Sandström, Thomas

AU - Sun, Kai

AU - Pandis, Ioannis

AU - Auffray, Charles

AU - de Meulder, Bertrand

AU - Sousa, Diane Lefaudeux Ana R.

AU - Dahlen, Sven Erik

AU - Adcock, Ian M.

AU - Chung, Kian Fan

AU - Sterk, Peter J.

AU - Skipp, Paul J.

AU - Riley, John H.

AU - Collins, Jane E.

AU - Davies, Donna E.

AU - Djukanovic, Ratko

AU - Ahmed, H.

AU - Banssal, A. T.

AU - Baribaud, F.

AU - Bates, S.

AU - Bel, E. H.

AU - Bigler, J.

AU - Bisgaard, H.

AU - Boedigheimer, M. J.

AU - Bønnelykke, K.

AU - Brinkman, P.

AU - Bucchioni, E.

AU - Burg, D.

AU - Bush, A.

AU - Bont, Louis

N1 - Funding Information: Support statement: U-BIOPRED is supported through an Innovative Medicines Initiative Joint Undertaking under grant agreement number 115010, resources of which are composed of financial contribution from the European Union’s Seventh Framework Program (FP7/2007–2013) and European Federation of Pharmaceutical Industries and Associations companies’ in-kind contribution (www.imi.europa.eu). J.M. Perotin was supported by the European Respiratory Society (fellowship LTRF 2017), Association Régionale pour l’Aide aux Insuffisants Respiratoires de Champagne-Ardenne, Association Nationale de Formation Continue en Allergologie, Association des Allergologues de Champagne-Ardenne and Association des Pneumologues de Champagne-Ardenne. Funding information for this article has been deposited with the Crossref Funder Registry. Funding Information: Acknowledgements: J-M. Perotin is the recipient of a European Respiratory Society Long-Term Fellowship (LTRF 2017) and received additional funding to support her research in Southampton, UK, from the Association Régionale pour l’Aide aux Insuffisants Respiratoires de Champagne-Ardenne, Association Nationale de Formation Continue en Allergologie, Association des Allergologues de Champagne-Ardenne and Association des Pneumologues de Champagne-Ardenne. This funding is gratefully acknowledged. Funding Information: U-BIOPRED is supported through an Innovative Medicines Initiative Joint Undertaking under grant agreement number 115010, resources of which are composed of financial contribution from the European Union's Seventh Framework Program (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations companies' in-kind contribution (www.imi.europa.eu). J.M. Perotin was supported by the European Respiratory Society (fellowship LTRF 2017), Association R?gionale pour l'Aide aux Insuffisants Respiratoires de Champagne-Ardenne, Association Nationale de Formation Continue en Allergologie, Association des Allergologues de Champagne-Ardenne and Association des Pneumologues de Champagne-Ardenne. Funding information for this article has been deposited with the Crossref Funder Registry.

PY - 2019/6/1

Y1 - 2019/6/1

UR - http://www.scopus.com/inward/record.url?scp=85069236701&partnerID=8YFLogxK

U2 - 10.1183/13993003.00453-2019

DO - 10.1183/13993003.00453-2019

M3 - Letter

C2 - 31023846

AN - SCOPUS:85069236701

SN - 0903-1936

VL - 53

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 6

M1 - 1900453

ER -